Charles River Laboratories (CRL) Tops Q2 EPS by 8c; Narrow FY EPS Guidance Range
Tweet Send to a Friend
Charles River Laboratories International, Inc. (NYSE: CRL) reports Q2 EPS of $0.66, 8 cents better than the analyst estimate of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
